Security key
218352102
CORCEPT THERAPEUTICS INC - COMMON STOCK (CORT)
CUSIP: 218352102
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 79,443,668
- Total 13F value
- $3,201,576,900
- Share change
- +2,958,490
- Put/Call ratio
- 208%
- SEC-reported price per share
- $40.31
- Number of holders
- 348
- Value change
- +$152,593,478
- Number of buys
- 176
- Number of sells
- 219
- Shares outstanding
- 106,815,676
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
348
Top holders
10
CORT full security history
Ownership snapshot
Full 13F holder table
CORCEPT THERAPEUTICS INC SEC filings
CORCEPT THERAPEUTICS INC company facts
Broader feeds
Ownership snapshot
Top reported holders of CORT - CORCEPT THERAPEUTICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G
13F
Lead comparable stake: 11%
13D/G row: BlackRock, Inc.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
11%
INGALLS & SNYDER LLC
6.8%
Joseph K. Belanoff
6.3%
RENAISSANCE TECHNOLOGIES LLC
5.5%
VANGUARD GROUP INC
8.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
13F
Company
|
11%
|
$846,969,867
11,539,099 shares
|
-$132,857,230 | 30 Jun 2025 |
| INGALLS & SNYDER LLC |
13D/G
13F
Company
|
6.8%
|
$292,790,314
7,263,466 shares
|
-$36,692,379 | 31 Dec 2025 |
| Joseph K. Belanoff |
13D/G
|
6.3%
|
$499,599,592
6,822,335 shares
|
$0 | 31 Dec 2024 |
| RENAISSANCE TECHNOLOGIES LLC |
13D/G
13F
Company
|
5.5%
|
$200,396,774
5,758,528 shares
|
$0 | 31 Dec 2025 |
| VANGUARD GROUP INC |
13F
Company
|
8.9%
|
$330,419,806
9,494,822 shares
|
— | 31 Dec 2025 |
| Parallel Advisors, LLC |
13F
Company
|
3.6%
|
$134,994,107
3,879,141 shares
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
348
Shares
79,443,668
Rows available
348
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q1 2026 Across Filers
Q1 2026 holders
348
Q1 2026 holders
348
Holder diff
0
| Investor | Q1 2026 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2026 value | Value change | Value Chg % |
|---|